Introduced

Passed House

Passed Senate

Became law

Adjourned sine die. The bill was pending when the session ended, so it did not pass.

Last action · January 14, 2026

To Health Services (H)

Introduced January 7, 2026

House

Adjourned Sine Die

2026 Regular Session

HB156

AN ACT relating to intranasal epinephrine.

Amend KRS 158.832 to include intranasal epinephrine to list of medications used to treat anaphylaxis; amend KRS 158.836 to include intranasal epinephrine as permissible for schools to keep.

Children and Minors Drugs and Medicines Education, Elementary and Secondary Health and Medical Services

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill would update Kentucky law to add intranasal epinephrine, a nasal-spray form of allergy emergency medicine, to the list of medications schools are allowed to keep on hand to treat severe allergic reactions known as anaphylaxis. Currently, the law covers other forms of epinephrine, and this change would expand the options available to schools. It gives schools another tool to respond quickly if a student has a life-threatening allergic reaction. Who it may affect: students in Kentucky public and private K-12 schools, school staff, and parents of children with severe allergies.

Open official bill text (PDF)·Report a problem with the summary